Author:
Barrios Dulce M.,Do Mytrang H.,Phillips Gregory S.,Postow Michael A.,Akaike Tomoko,Nghiem Paul,Lacouture Mario E.
Funder
National Institutes of Health
Reference112 articles.
1. Tumor immunotherapy directed at PD-1;Ribas;N Engl J Med,2012
2. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front Pharmacol,2017
3. Molecular and biochemical aspects of the PD-1 checkpoint pathway;Boussiotis;N Engl J Med,2016
4. PD-L1 studies across tumor types, its differential expression and predictive value in patients treated with immune checkpoint inhibitors;Kluger;Clin Cancer Res,2017
5. Cutaneous melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Coit;J Natl Compr Canc Netw,2019
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献